Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT02642432
Eligibility Criteria:
Inclusion Criteria:
* Screening laboratory result indicating hepatitis C virus (HCV) Genotype 1, 2, 4, 5 or 6 (GT1,2,4,5,6) infection
* Chronic HCV infection
* Subject must be HCV treatment-naïve or have failed prior HCV treatment
* Subject must have documented compensated cirrhosis and no current or past clinical evidence of decompensated liver disease
Exclusion Criteria:
* Positive test result at screening for Hepatitis B surface antigen or anti-human immunodeficiency virus (anti-HIV) antibody
* HCV genotype performed during screening indicating co-infection with more than 1 HCV genotype
* Consideration by the investigator, for any reason, that the subject is an unsuitable candidate to receive ABT-493/ABT-530
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02642432
Study Brief:
Protocol Section:
NCT02642432